Medical Equipment

Poc Hba1C Testing Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries

March 16, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Poc Hba1C Testing Market From 2026 To 2030?

The poc hba1c testing market size has seen rapid growth over recent years. It is anticipated to expand from $1.02 billion in 2025 to $1.14 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.9%. This historical growth is attributable to factors such as the increasing global prevalence of diabetes, greater clinical reliance on long-term glucose monitoring, the expansion of outpatient diagnostic services, heightened awareness regarding early diabetes diagnosis, and the availability of compact diagnostic instruments.

The poc hba1c testing market size is anticipated to experience substantial expansion in the coming years. By 2030, this market is projected to reach $1.76 billion, exhibiting a compound annual growth rate (CAGR) of 11.4%. This projected expansion is driven by factors such as the greater embrace of decentralized diagnostics, a surging need for home care testing options, the broadening of digital diabetes management initiatives, a heightened emphasis on preventive healthcare, and increased funding for rapid diagnostic innovations. Key developments anticipated during this timeframe involve the wider integration of rapid point-of-care hba1c devices, an increase in the utilization of portable and handheld testing systems, a heightened desire for at-home diabetes monitoring, the broadening of integrated poc diagnostic platforms, and a strengthened commitment to test precision and consistency.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6833&type=smp

What Major Drivers Are Influencing Demand In The Poc Hba1C Testing Market?

The escalating occurrence of diabetes is propelling the expansion of the point-of-care (POC) HbA1C testing market. Diabetes, a chronic metabolic condition, is characterized by elevated blood glucose levels, which require ongoing monitoring to prevent severe complications such as neuropathy, cardiovascular disease, and renal impairment. This global increase in diabetes cases is primarily fueled by factors including sedentary lifestyles, unhealthy dietary patterns, obesity, and an aging population. The rising prevalence of diabetes consequently bolsters the POC HbA1C testing market by amplifying the demand for rapid, convenient, and accurate assessments of glycemic control in various settings like clinics, pharmacies, and home-care, thereby enabling prompt treatment decisions. For instance, in 2025, according to the International Diabetes Federation, a Belgium-based health organization, in 2024, approximately 589 million adults aged 20-79 were living with diabetes, with the total number projected to reach 853 million by 2050, and more than 4 in 5 adults with diabetes residing in low and middle income countries. Therefore, the expanding prevalence of diabetes is significantly driving the growth of the POC hba1c testing market.

Which Segments Are Included In The Analysis Of The Poc Hba1C Testing Market?

The poc hba1c testing market covered in this report is segmented –

1) By Type of Product: Instruments, Consumables

2) By Technology: Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Immunoassay, Other Technologies

3) By End User: Hospitals, Physician Office Or Outpatient Center, Home Care, Other End Users

Subsegments:

1) By Instruments: Handheld HbA1c Testing Devices, Portable HbA1c Analyzers, Desktop HbA1c Testing Systems, Integrated Point Of Care Testing Systems

2) By Consumables: Test Strips, Control Solutions, Reagents, Calibration Solutions, Sample Collection Devices

Which Trends Are Impacting The Growth Of The Poc Hba1C Testing Market?

Leading companies in the point-of-care (POC) HbA1c testing market are increasingly incorporating integrated internal verification systems to guarantee test accuracy, minimize error potential, and build confidence in near-patient diagnostics. These self-monitoring features consistently check environmental factors, sample quality, and assay performance during each test to prevent incorrect outcomes or sample wastage. For instance, in July 2024, Siemens Healthineers, a Germany-based company specializing in medical technology, unveiled its next-generation point-of-care Atellica DCA Analyser. The Atellica DCA Analyzer utilizes its unique Auto-Checks Technology, which performs a series of internal calibrations and validations throughout the testing process, including environmental calibration, airflow and thermal verification, sample volume and integrity checks, optical clarity, and precision evaluations. This automated self-supervision ensures that every HbA1c result, delivered in just 4–5 minutes, meets lab-equivalent quality standards, while also lessening the need for constant operator oversight. By embedding these automatic checks, the Atellica DCA helps to reduce pre-analytical errors, boost result reliability, and facilitate the expansion of point of care (POC) testing in environments with limited laboratory facilities.

Which Key Industry Participants Are Active In The Poc Hba1C Testing Market?

Major companies operating in the poc hba1c testing market are F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Bio-Rad Laboratories Inc, Menarini Group, Danaher Corporation, Tosoh Bioscience Inc, ARKRAY Inc, i-SENS Inc, Abbott Laboratories, Trinity Biotech plc, Aina Blood Monitoring System, Getein Biotech Inc, Sugentech Inc, Alere Inc, EKF Diagnostics, HemoCue, PTS Diagnostics, Osang Healthcare, Ortho Clinical Diagnostics, Ascensia, Platinum Equity (LifeScan), Becton Dickinson and Company, Kainico Ltd, Evia Medical Technologies, Agamatrix Inc, Bionime Corporation

Read the full poc hba1c testing market report here:

https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Poc Hba1C Testing Market?

North America was the largest region in the POC HbA1C testing market in 2025. Africa is expected to be the fastest-growing region in the forecast- period. The regions covered in the poc hba1c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Poc Hba1C Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6833&type=smp

Browse Through More Reports Similar to the Global Poc Hba1C Testing Market 2026, By The Business Research Company

Hemoglobin A1C Hba1C Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Poc Cholesterol Test Market 2026

https://www.thebusinessresearchcompany.com/report/poc-cholesterol-test-market

Hemoglobin A1C Testing Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-testing-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795